Figure 4 A column presentation compared duration of adverse reactions reported after 2 nd  and 3 rd  Pfizer-BioNTech vaccine doses. Data were presented as the percentage of individuals who have reported a particular duration relative to the total number of individuals who have experienced the adverse reactions (n=340 for the 2 nd  dose and 349 for 3 rd  dose). p value derived from Fisher’s exact test.